Respiratory Hypersensitivity: Clinical Trials

20 trials for Respiratory Hypersensitivity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

20 completed. 20 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 120Completed 20

Follow Respiratory Hypersensitivity: new trials by email Literature Review of Respiratory Hypersensitivity trials Research Report on Respiratory Hypersensitivity

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination of Oral Supplement With Fatty Acids, Vitamin B6, Perilla, and Liquorice With Nasal Steroids for the Treatment of Allergic Rhinitis
Oral fatty acid, Mometasone Furoate Nasal Spray (MFNS) - Allergic Rhinitis
Early Phase 1CompletedIsola Tiberina - Gemelli Isola Hospital, Rome, Italy4002024-09-012025-06-12
Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control Study
Polvac Grass+Rye - Hypersensitivity, Hay Fever
Early Phase 1CompletedUniversity of Zurich282023-11-232025-05-21
Effectiveness of a Mobile Health Intervention in Improving the Technique of Inhaled Medications Among Children With Asthma
BreatheSuite - Asthma, Asthma in Children
Early Phase 1CompletedMemorial University of Newfoundland302021-01-012022-04-08
Ginger's Therapeutic Potential in Asthma
Ginger Extract, Placebo - Asthma
Early Phase 1CompletedEmily DiMango, MD542019-08-222023-03-27
GSNOR Phenotyping/GSNO Challenge in Severe Asthma
GSNO Challenge - Asthma
Early Phase 1CompletedJames Reynolds482019-04-302026-05-20
Defining and Treating Depression-related Asthma
Ipratropium Bromide - Asthma, Depression
Early Phase 1CompletedState University of New York at Buffalo392016-09-092026-04-23
Compare the Effect of INS Alone and Added LTRA in Treatment of SAR
budesonide - Allergic Rhinitis
Early Phase 1CompletedBeijing Tongren Hospital462016-06-012019-09-04
In Vitro Evaluation of a Novel Drug on Airway Epithelial Cells Obtained From Participants With Severe Asthma
VR588 - Asthma
Early Phase 1CompletedImperial College London92016-01-272019-10-28
The Leaky Lung Test
Mannitol - Asthma, Allergy
Early Phase 1CompletedUniversity of Rochester1002015-10-012018-01-04
A Study to Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy Participants
Allergic Skin Reaction (ASR) Testing and Skin Blister Induction - Dermatitis, Atopic, Asthma
Early Phase 1CompletedJanssen Research & Development, LLC462015-01-012015-10-06
Study of a Topical Nasal Spray to Ease the Symptoms of Hayfever
C-1266-7, C-1266-6 (placebo) - Rhinitis, Allergic, Seasonal
Early Phase 1CompletedMcNeil Consumer Healthcare Division of McNEIL-PPC, Inc.212012-01-012017-02-27
Inhaled Iloprost in Mild Asthma
Iloprost - Asthma
Early Phase 1CompletedVanderbilt University242010-09-012011-08-03
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Medical tests - Asthma, Pulmonary Disease, Chronic Obstructive
Early Phase 1CompletedJanssen Research & Development, LLC3282010-07-012016-12-20
Role of Cigarette Smoking in Regulating Allergen-induced Early and Late Responses in Mild Asthmatics
Allergen Challenge - Asthma
Early Phase 1CompletedHamilton Health Sciences Corporation252008-08-012013-04-24
Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fasted Conditions
Montelukast, Singulair - Asthma
Early Phase 1CompletedRoxane Laboratories352008-08-012018-01-23
Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fed Conditions
Montelukast, Singulair - Asthma
Early Phase 1CompletedRoxane Laboratories362008-08-012018-01-23
Bioequivalency Study of Montelukast 10 mg Tablets Under Fasted Conditions
Montelukast, Singulair - Asthma
Early Phase 1CompletedRoxane Laboratories342008-02-012018-01-23
The Effect of Allergen Inhalation on Sputum Myeloid and Plasmacytoid Dendritic Cells in Mild Atopic Asthmatics
Aeroallergen - Asthma
Early Phase 1CompletedHamilton Health Sciences Corporation122008-02-012018-05-21
Bioequivalency Study of Montelukast 10 mg Tablets Under Fed Conditions
Montelukast, Singulair - Asthma
Early Phase 1CompletedRoxane Laboratories352008-02-012018-01-23
Mannitol Bronchoprovocation Challenge Ancillary Study/ACRN
mannitol - Asthma
Early Phase 1CompletedUniversity of Wisconsin, Madison662007-12-012019-08-19

Narrower conditions

Asthma (16)  ·  Rhinitis, Allergic (3)  ·  Hypersensitivity (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Rhinitis, Allergic, Seasonal (2)  ·  Blister (1)  ·  Depression (1)  ·  Dermatitis, Atopic (1)  ·  Lung Diseases, Obstructive (1)  ·  Rhinosinusitis (1)  ·  Smoking (1)

Broader conditions

Hypersensitivity, Immediate (20)  ·  Immune System Diseases (20)  ·  Respiratory Tract Diseases (20)  ·  Hypersensitivity (18)  ·  Bronchial Diseases (16)  ·  Lung Diseases (16)  ·  Lung Diseases, Obstructive (15)  ·  Nose Diseases (4)  ·  Otorhinolaryngologic Diseases (4)  ·  Rhinitis (4)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Behavior (2)  ·  Chronic Disease (2)  ·  Disease Attributes (2)

Interventions

montelukast (5)  ·  Mannitol (2)  ·  Budesonide (1)  ·  Fatty Acids (1)  ·  Iloprost (1)  ·  Ipratropium (1)  ·  ginger extract (1)

Sponsors

Roxane Laboratories (4)  ·  Hamilton Health Sciences Corporation (2)  ·  Janssen Research & Development, LLC (2)  ·  Beijing Tongren Hospital (1)  ·  Emily DiMango, MD (1)  ·  Imperial College London (1)  ·  Isola Tiberina - Gemelli Isola Hospital, Rome, Italy (1)  ·  James Reynolds (1)  ·  McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. (1)  ·  Memorial University of Newfoundland (1)  ·  State University of New York at Buffalo (1)  ·  University of Rochester (1)  ·  University of Wisconsin, Madison (1)  ·  University of Zurich (1)  ·  Vanderbilt University (1)

Countries

United States (12)  ·  Canada (4)  ·  Germany (2)  ·  United Kingdom (2)  ·  Belgium (1)  ·  China (1)  ·  Denmark (1)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Romania (1)  ·  Switzerland (1)

Top investigators

Alan K Copa, PharmD (4)  ·  Gail Gauvreau, PhD (2)  ·  Paul O'Byrne, MD (2)  ·  Christine A Sorkness, Pharm.D. (1)  ·  Daniel S Qi, MD, PhD (1)  ·  Emily DiMango, MD (1)  ·  Fan Chung, MD (1)  ·  Heather K Lehman, MD (1)  ·  James Sheller, M.D. (1)  ·  Kristie Ross, MD (1)  ·  Mary Jane Smith, MD (1)  ·  Peter Schmid-Grendelmeier, Prof. MD (1)  ·  Steve N Georas, M.D. (1)  ·  Zhang Luo (1)

Results publications

PMID 19001265, PMID 27978840, PMID 32679209, PMID 32883677, PMID 33099797

NIH funding

2023 (1), P01HL158507 (1), R01HL122424 (1), R61AT009989 (1), UL1TR001412 (1)